» Articles » PMID: 17388997

Cerebral Embolism with Interventional Closure of Symptomatic Patent Foramen Ovale: an MRI-based Study Using Diffusion-weighted Imaging

Overview
Journal Eur J Neurol
Publisher Wiley
Specialty Neurology
Date 2007 Mar 29
PMID 17388997
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Paradoxical embolism via patent foramen ovale (PFO) is an important cause of stroke, especially in younger patients. Transcatheter PFO closure is considered to bear a low risk and to be technically feasable with a high primary success rate. There are no data for the rate of procedure-associated silent embolic events. The present study sought to analyze the total number of cerebral ischemic complications with interventional PFO closure. Thirty-five symptomatic PFO patients (15 male, 26-71 years) with cerebral infarctions proven by magnetic resonance imaging (MRI) were examined by diffusion-weighted imaging (DWI) before and after PFO closure. In the MRI examinations following the intervention, new microembolic lesions were found in three of 35 (8.6%) patients. The lesions were located in the right and left thalamus and the left frontoparietal white matter respectively. Two of three infarcts were clinically inapparent, whereas the third patient suffered from a transient right-sided hemihypaesthesia for 12 h. If the prevention of recurrent cerebrovascular events associated with the presence of PFO is necessary, a low frequency of closure associated silent cerebral embolisms was documented after interventional PFO closure. The rate of microembolic events with neurological deficit was 1/35 (approximately 2.8%).

Citing Articles

Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures.

Lenarczyk R, Proietti M, Scheitz J, Shah D, Siebert E, Gorog D Nat Rev Cardiol. 2024; .

PMID: 39394524 DOI: 10.1038/s41569-024-01076-0.


Cerebral Embolic Risk in Coronary and Structural Heart Interventions: Clinical Evidence.

Tirziu D, Huang H, Parise H, Pietras C, Moses J, Messe S J Soc Cardiovasc Angiogr Interv. 2024; 2(3):100631.

PMID: 39130705 PMC: 11307836. DOI: 10.1016/j.jscai.2023.100631.


Cerebral embolic protection during transcatheter heart interventions.

Jimenez Diaz V, Kapadia S, Linke A, Mylotte D, Lansky A, Grube E EuroIntervention. 2023; 19(7):549-570.

PMID: 37720969 PMC: 10495748. DOI: 10.4244/EIJ-D-23-00166.


Multi-national survey on the methods, efficacy, and safety on the post-approval clinical use of pulsed field ablation (MANIFEST-PF).

Ekanem E, Reddy V, Schmidt B, Reichlin T, Neven K, Metzner A Europace. 2022; 24(8):1256-1266.

PMID: 35647644 PMC: 9435639. DOI: 10.1093/europace/euac050.


Silent cerebral emboli following percutaneous closure of atrial septal defect in pediatric patients: a diffusion-weighted MRI study.

Koc G, Ozyurt A, Doganay S, Baykan A, Gorkem S, Dogan M Diagn Interv Radiol. 2015; 22(1):90-4.

PMID: 26394443 PMC: 4712904. DOI: 10.5152/dir.2015.15104.